Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
PaperCitations, authors & open-access status
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 164 citations, 2016 year and bronze oa status.
164
Citations
2016
Year
bronze
OA Status